Joshua Eloge
Psychiatry · Skokie, ILNPI 1215254099
Payments from drug & device makers
Across 402 payments — averaging $25.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Lundbeck LLC$1K
- Neurocrine Biosciences, Inc.$594
- Otsuka America Pharmaceutical, Inc.$450
- Corium, LLC$438
- plus $3K from 28 others
What the payments were for
- Consulting fees$1,10011%
- Food & beverage$8,96989%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 111 | $2,555 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 63 | $1,585 |
| Lundbeck LLC | 35 | $1,023 |
| Neurocrine Biosciences, Inc. | 17 | $594 |
| Otsuka America Pharmaceutical, Inc. | 18 | $450 |
| Corium, LLC | 23 | $438 |
| Axsome Therapeutics, Inc. | 17 | $423 |
| Alkermes, Inc. | 18 | $406 |
| Johnson & Johnson | 14 | $406 |
| Biogen | 6 | $370 |
| Bausch Health US, LLC | 12 | $215 |
| Tris Pharma Inc | 9 | $185 |
| Livanova USA, Inc. | 2 | $164 |
| Sunovion Pharmaceuticals Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 5 | $114 |
| Ironshore Pharmaceuticals Inc. | 5 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $105 |
| Neos Therapeutics, LP | 5 | $104 |
| Harmony Biosciences LLC | 4 | $85 |
| USWM, LLC | 4 | $82 |
| Almatica Pharma LLC | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| Indivior Inc. | 3 | $62 |
| Idorsia Pharmaceuticals US Inc | 3 | $56 |
| Noven Therapeutics, LLC | 3 | $54 |
| Eisai Inc. | 2 | $51 |
| Abbott | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 1 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Genentech, Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,094 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LybalviOlanzapine/Samidorphan Malate | 13 | $19,352 |
| VraylarCariprazine Hcl | 13 | $17,692 |
| Quetiapine Fumarate | 17 | $563 |
| Modafinil | 13 | $379 |
| Lamotrigine | 14 | $273 |
| Trazodone Hcl | 26 | $243 |
| Clonazepam | 36 | $209 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $199 |
| Lithium Carbonate ErLithium Carbonate | 16 | $185 |
| Sertraline Hcl | 18 | $177 |
| Escitalopram Oxalate | 16 | $167 |
| Bupropion XlBupropion Hcl | 23 | $145 |
| Lorazepam | 30 | $142 |
| Propranolol Hcl | 11 | $124 |
| Mirtazapine | 14 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alkermes, Inc.Lybalvi | $406 | $19,35213 claims |
| AbbVieVraylar | $2,555 | $17,69213 claims |
| Almatica Pharma LLCSertraline Hcl | $67 | $17718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Skokie
- John ZajeckaSkokie$2.5M
- Mark ShukhmanSkokie$250K
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.